Search

2 result(s) for 'author#Kozo Kumakawa' within BMC

1. A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment

   To date, no therapeutic option has been established for sudden deafness refractory to systemic corticosteroids. This study aimed to examine the efficacy and safety of topical insulin-like growth factor-1 (IGF-...

   Authors: Takayuki Nakagawa, Kozo Kumakawa, Shin-ichi Usami, Naohito Hato, Keiji Tabuchi, Mariko Takahashi, Keizo Fujiwara, Akira Sasaki, Shizuo Komune, Tatsunori Sakamoto, Harukazu Hiraumi, Norio Yamamoto, Shiro Tanaka, Harue Tada, Michio Yamamoto, Atsushi Yonezawa…

   Citation: BMC Medicine 2014 12:219

   Content type: Research article Published on: 19 November 2014

   • View Full Text
   • View PDF

2. OTOF mutation screening in Japanese severe to profound recessive hearing loss patients

   Auditory neuropathy spectrum disorder (ANSD) is a unique form of hearing loss that involves absence or severe abnormality of auditory brainstem response (ABR), but also the presence of otoacoustic emissions (O...

   Authors: Yoh-ichiro Iwasa, Shin-ya Nishio, Hidekane Yoshimura, Yukihiko Kanda, Kozo Kumakawa, Satoko Abe, Yasushi Naito, Kyoko Nagai and Shin-ichi Usami

   Citation: BMC Medical Genetics 2013 14:95

   Content type: Research article Published on: 22 September 2013

   • View Full Text
   • View PDF